At the news
? NEUTRALIMPACT 2/10 144 filed Apr 15, 2026 at 16:11 ET
Saira Ramasastry, a director at Mirum Pharmaceuticals, filed a Form 144 to notify the sale of 2,000 shares of common stock, valued at approximately $193,800, following a stock option exercise. The shares are intended for sale on or after April 15, 2026.
- Saira Ramasastry is a director at Mirum Pharmaceuticals.
- Filed Form 144 for the proposed sale of 2,000 shares of common stock.
- Shares to be sold following a stock option exercise on April 15, 2026.
- Approximate sale value: $193,800 (based on $96.90/share).
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access